JP2008525427A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525427A5
JP2008525427A5 JP2007547787A JP2007547787A JP2008525427A5 JP 2008525427 A5 JP2008525427 A5 JP 2008525427A5 JP 2007547787 A JP2007547787 A JP 2007547787A JP 2007547787 A JP2007547787 A JP 2007547787A JP 2008525427 A5 JP2008525427 A5 JP 2008525427A5
Authority
JP
Japan
Prior art keywords
nik
agent
binding
amino acids
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007547787A
Other languages
English (en)
Japanese (ja)
Other versions
JP5686940B2 (ja
JP2008525427A (ja
Filing date
Publication date
Priority claimed from IL16600604A external-priority patent/IL166006A0/xx
Application filed filed Critical
Publication of JP2008525427A publication Critical patent/JP2008525427A/ja
Publication of JP2008525427A5 publication Critical patent/JP2008525427A5/ja
Application granted granted Critical
Publication of JP5686940B2 publication Critical patent/JP5686940B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007547787A 2004-12-27 2005-12-11 NF−κB活性と関連する疾患を治療するための医薬組成物 Expired - Fee Related JP5686940B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL166006 2004-12-27
IL16600604A IL166006A0 (en) 2004-12-27 2004-12-27 Pharmaceutical compositions for treating diseases associated with nf-kb activity
PCT/IL2005/001335 WO2006070348A1 (en) 2004-12-27 2005-12-11 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY

Publications (3)

Publication Number Publication Date
JP2008525427A JP2008525427A (ja) 2008-07-17
JP2008525427A5 true JP2008525427A5 (https=) 2009-01-29
JP5686940B2 JP5686940B2 (ja) 2015-03-18

Family

ID=36072106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007547787A Expired - Fee Related JP5686940B2 (ja) 2004-12-27 2005-12-11 NF−κB活性と関連する疾患を治療するための医薬組成物

Country Status (9)

Country Link
US (1) US8338567B2 (https=)
EP (1) EP1838347B1 (https=)
JP (1) JP5686940B2 (https=)
AU (1) AU2005320905B2 (https=)
CA (1) CA2593035C (https=)
ES (1) ES2518340T3 (https=)
IL (2) IL166006A0 (https=)
NO (1) NO20073942L (https=)
WO (1) WO2006070348A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2527434B1 (en) 2010-01-22 2017-08-09 Japan Science and Technology Agency Probe reagent for measurement of proteolytic activity
EP3041859A2 (en) * 2013-09-03 2016-07-13 INSERM - Institut National de la Santé et de la Recherche Médicale Compositions and methods for inducing senescence in cancer cells
US12059413B2 (en) 2016-11-02 2024-08-13 The Research Foundation For The State University Of New York Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
AU2877899A (en) * 1998-02-27 1999-09-15 Regents Of The University Of California, The A novel inhibitor of the inflammatory response induced by tnfalpha and il-1
ITMI20010402U1 (it) 2001-07-18 2003-01-18 Valerio Leccacorvi Rivestimento per le superfici di una piscina
CA2482718C (en) * 2002-04-18 2014-08-19 Yeda Research And Development Co. Ltd. Derivatives of the il-2 receptor gamma chain, their production and use

Similar Documents

Publication Publication Date Title
Mitrea et al. Disorder-function relationships for the cell cycle regulatory proteins p21 and p27.
EP2061886B1 (en) Small cationic immunomodulatory peptides
Rai Peptide and protein mimetics by retro and retroinverso analogs
JP2004536614A5 (https=)
JP2007529204A5 (https=)
CN101264326A (zh) 阿尔茨海默氏病的治疗方法
JP2011502964A5 (https=)
JP2019525753A5 (https=)
JP2017524382A5 (https=)
JP2000312590A5 (https=)
WO2006090810A3 (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
JP2002505841A5 (https=)
JP2009540852A5 (https=)
JP2006506942A5 (https=)
ATE369440T1 (de) Rationale auswahl von mutmasslichen peptiden aus identifizierten nukleotid- beziehungsweise peptidsequenzen
JP2017528129A5 (https=)
Chen et al. Development of membrane‐active peptide therapeutics in oncology
JP2008525427A5 (https=)
JP2020500150A5 (https=)
JP2007521799A5 (https=)
K Tannenberg et al. Nucleic acid aptamers as novel class of therapeutics to mitigate Alzheimer's disease pathology
JP2019038772A5 (https=)
Denholt et al. Identification of novel peptide ligands for the cancer‐specific receptor mutation EFGRvIII using a mixture‐based synthetic combinatorial library
JP2013542720A5 (https=)
RU2013118454A (ru) Антитело к эфрину в2 и его применение